The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Taiho Pharmaceutical
Mass balance study of TAS-102 using 14C labeling analyzed by accelerator mass spectrometry.
 
James J. Lee
Consulting or Advisory Role - Bayer; Sanofi
Research Funding - Merck
 
Jabed Seraj
No Relationships to Disclose
 
Kenichiro Yoshida
Employment - Taiho Pharmaceutical
 
Milind Narurkar
Employment - Taiho Pharmaceutical
 
Hirokazu Mizuguchi
Employment - Taiho Pharmaceutical
 
Sandra Strychor
No Relationships to Disclose
 
Jillian Fiejdasz
No Relationships to Disclose
 
Tyeler Faulkner
No Relationships to Disclose
 
Laura Pollice
No Relationships to Disclose
 
Scott Mason
No Relationships to Disclose
 
Weijing Sun
No Relationships to Disclose
 
Edward Chu
No Relationships to Disclose
 
Marie Croft
Stock and Other Ownership Interests - Xceleron
 
James Nguteren
No Relationships to Disclose
 
Charles Tedder
No Relationships to Disclose
 
Jan Hendrik Beumer
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - BTG; Saladax Biomedical
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Millennium (Inst); Novartis (Inst); Saladax Biomedical (Inst); Spectrum Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)